FOUNTIL LIFE SCIENCES

fountil.com

”Fountil Life Sciences”* is fueled by a dynamic vision of emerging within top 10 players in 10 therapeutic segments in the next 10 years in the domestic & export markets in Africa and Asia.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

FOSUN PHARMA AND INSILICO MEDICINE ANNOUNCE A STRATEGIC, AI-DRIVEN DRUG DISCOVERY AND DEVELOPMENT COLLABORATION TO JOINTLY ADVANCE MULTIPLE TARGETS

Insilico Medicine | January 18, 2022

news image

Shanghai Fosun Pharmaceutical Co., Ltd, a leading innovation-driven international healthcare group in China and Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and development company, entered into a collaboration agreement to advance the discovery and development of drugs targeting a number of different targets globally through the use of AI technology. This strategic collaboration includes an AI-driven drug discovery research and development (...

Read More

Pharmacy Market

TONIX PHARMACEUTICALS COMPLETES CLINICAL PHASE OF PREVAIL PROOF-OF-CONCEPT STUDY OF TNX-102 SL FOR THE TREATMENT OF FIBROMYALGIA-TYPE LONG COVID

Globenewswire | August 14, 2023

news image

Tonix Pharmaceuticals Holding Corp. a biopharmaceutical company, today announced the completion of the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL as a potential treatment for fibromyalgia-type Long COVID. Topline results for the PREVAIL study are expected in the third quarter of 2023. “Approximately 40% of U.S. Long COVID patients have fibromyalgia-like multi-site pain symptoms based on our observational studies of Long COVID patients from t...

Read More

Business Insights

BIOCYTOGEN EXPANDS PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY

Biocytogen and Merck KGaA, Darmstadt, Germany | August 26, 2022

news image

Biocytogen Pharmaceuticals Co., Ltd. entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for the use of Biocytogen’s RenMiceTM platform. Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibody therapeutics for an unlimited number of drug targets. Merck KGaA, Darmstadt, Germany will be responsible for all clinical development, manufacturing, and com...

Read More

CVS HEAD OF SPECIALTY PHARMACY SEES FUTURE OF HEALTHCARE AT HOME AFTER COVID-19

Medcity news | May 26, 2020

news image

Mail-order prescriptions are nothing new, but pharmacists have turned to a number of other tools to help patients access their prescriptions during the Covid-19 pandemic. The head of CVS Health’s specialty pharmacy strategy, Prem Shah, said he expects to see more patients continue receive healthcare at home after the pandemic ends. Though CVS Health had been building up its arsenal of digital tools before the Covid-19 pandemic, stay-at-home orders forced the pharmacy giant to lean mo...

Read More
news image

Business Insights

FOSUN PHARMA AND INSILICO MEDICINE ANNOUNCE A STRATEGIC, AI-DRIVEN DRUG DISCOVERY AND DEVELOPMENT COLLABORATION TO JOINTLY ADVANCE MULTIPLE TARGETS

Insilico Medicine | January 18, 2022

Shanghai Fosun Pharmaceutical Co., Ltd, a leading innovation-driven international healthcare group in China and Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and development company, entered into a collaboration agreement to advance the discovery and development of drugs targeting a number of different targets globally through the use of AI technology. This strategic collaboration includes an AI-driven drug discovery research and development (...

Read More
news image

Pharmacy Market

TONIX PHARMACEUTICALS COMPLETES CLINICAL PHASE OF PREVAIL PROOF-OF-CONCEPT STUDY OF TNX-102 SL FOR THE TREATMENT OF FIBROMYALGIA-TYPE LONG COVID

Globenewswire | August 14, 2023

Tonix Pharmaceuticals Holding Corp. a biopharmaceutical company, today announced the completion of the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL as a potential treatment for fibromyalgia-type Long COVID. Topline results for the PREVAIL study are expected in the third quarter of 2023. “Approximately 40% of U.S. Long COVID patients have fibromyalgia-like multi-site pain symptoms based on our observational studies of Long COVID patients from t...

Read More
news image

Business Insights

BIOCYTOGEN EXPANDS PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY

Biocytogen and Merck KGaA, Darmstadt, Germany | August 26, 2022

Biocytogen Pharmaceuticals Co., Ltd. entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for the use of Biocytogen’s RenMiceTM platform. Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibody therapeutics for an unlimited number of drug targets. Merck KGaA, Darmstadt, Germany will be responsible for all clinical development, manufacturing, and com...

Read More
news image

CVS HEAD OF SPECIALTY PHARMACY SEES FUTURE OF HEALTHCARE AT HOME AFTER COVID-19

Medcity news | May 26, 2020

Mail-order prescriptions are nothing new, but pharmacists have turned to a number of other tools to help patients access their prescriptions during the Covid-19 pandemic. The head of CVS Health’s specialty pharmacy strategy, Prem Shah, said he expects to see more patients continue receive healthcare at home after the pandemic ends. Though CVS Health had been building up its arsenal of digital tools before the Covid-19 pandemic, stay-at-home orders forced the pharmacy giant to lean mo...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us